论文标题
COVID-19病毒检测的集成空气质量监测系统
An Integrated Air Quality Monitoring System for COVID-19 Virus Detection
论文作者
论文摘要
综合征 - 核可纳病毒2(SARS-COV-2)引起的冠状病毒病(COVID-19)的大流行已被发现迅速,大规模诊断,以分布在整个社区中。传染性空气传播传播的风险一直是人们越来越关注的领域。在这方面,非常需要对SARS-COV-2气溶胶的选择性视频检测,该检测可以积极收集周围的空气样本并向用户提供实时反馈。在这项工作中,我们开发了一个集成的空气质量监测系统(IAQMS),该系统可实时具有高灵敏度的SARS-COV-2气溶胶检测。该检测设备灵感来自局部表面等离子体共振(LSPR),旨在测量通过生物芯片的光的强度变化,其中将金纳米颗粒(AUNP)与抗体结合使用,暴露于含有病毒气水的气流中。我们发现,暴露于病毒气溶胶350秒后测得的光电流的变化是病毒颗粒浓度的函数。通过将空气收集设备和光学检测设备纳入可以通过蓝牙串行与智能手机通信的手持式设备,我们展示了对SARS-COV-2病毒气溶胶的实时和敏感检测,其浓度动态范围为0.0000001-0.1 pfu/ul。由于其灵敏度和可靠性,我们的设备也可以通过简单地将抗体合并到生物芯片中的AUNP来检测其他病毒气溶胶。
The pandemic of coronavirus disease 2019 (COVID-19) caused by syndrome-coronavirus-2 (SARS-CoV-2) has been found rapid and large-scale diagnosis to spread across the communities. The risk of infectious airborne aerosol transmission has been an area of increasing concern. In this regard, a selective optic detection of SARS-CoV-2 aerosol is highly desirable, which can actively collect the surrounding air samples and provide real-time feedbacks to users. In this work, we developed an integrated Air Quality Monitoring System (iAQMS) that enables real-time SARS-CoV-2 aerosol detection with high sensitivity. The detection device, inspired by localized surface plasmon resonance (LSPR), was designed to measure the intensity changes of light going through our biochips in which gold nanoparticles (AuNP) combined with antibodies were exposed to airflow containing virus aerosols. We found that the variation of the measured photocurrent after 350 seconds of exposure to virus aerosols is a function of virus particle concentrations. By incorporating the air collection device and the optic detection device into a handheld sized device that can communicate with a smart-phone through Bluetooth serial, we demonstrate real-time and sensitive detection of SARS-CoV-2 virus aerosols with a concentration dynamic range of 0.00001 - 0.1 pfu/uL. Because of its sensitivity and reliability, our device can also be used for detection of other virus aerosols by simply switching the antibodies combined to the AuNP in the biochips.